Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2016 1
2017 1
2020 2
2022 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Listeria monocytogenes-associated spontaneous bacterial peritonitis in France: a nationwide observational study of 208 cases.
Blanchard F, Henry B, Vijayaratnam S, Canouï E, Moura A, Thouvenot P, Bracq-Dieye H, Tessaud-Rita N, Valès G, Diakité A, Leclercq A, Lecuit M, Charlier C; Listeria monocytogenes-associated Spontaneous Peritonitis Study Group. Blanchard F, et al. Lancet Infect Dis. 2024 Jul;24(7):783-792. doi: 10.1016/S1473-3099(24)00151-8. Epub 2024 Apr 9. Lancet Infect Dis. 2024. PMID: 38608698
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Debieuvre D, Molinier O, Falchero L, Locher C, Templement-Grangerat D, Meyer N, Morel H, Duval Y, Asselain B, Letierce A, Trédaniel J, Auliac JB, Bylicki O, Moreau L, Fore M, Corre R, Couraud S, Cortot A; Study Group KBP-2020-CPHG; KBP-2020-CPHG. Debieuvre D, et al. Lancet Reg Health Eur. 2022 Aug 29;22:100492. doi: 10.1016/j.lanepe.2022.100492. eCollection 2022 Nov. Lancet Reg Health Eur. 2022. PMID: 36108315 Free PMC article.
Duration of nivolumab for pretreated, advanced non-small-cell lung cancer.
Geier M, Descourt R, Corre R, Léveiller G, Lamy R, Goarant É, Bizec JL, Bernier C, Quéré G, Amrane K, Gaye E, Lucia F, Burte E, Chouaid C, Robinet G. Geier M, et al. Among authors: goarant e. Cancer Med. 2020 Oct;9(19):6923-6932. doi: 10.1002/cam4.3120. Epub 2020 May 15. Cancer Med. 2020. PMID: 32412157 Free PMC article.
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.
Amrane K, Geier M, Corre R, Léna H, Léveiller G, Gadby F, Lamy R, Bizec JL, Goarant E, Robinet G, Gouva S, Quere G, Abgral R, Schick U, Bernier C, Chouaid C, Descourt R. Amrane K, et al. Among authors: goarant e. Cancer Med. 2020 Apr;9(7):2309-2316. doi: 10.1002/cam4.2806. Epub 2020 Feb 5. Cancer Med. 2020. PMID: 32022459 Free PMC article. Clinical Trial.
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Debieuvre D, Fraboulet G, Duvert B, Piquet J, Goarant E, Sandron D, Mouroux-Rotomondo C, Borrel B, Genety C, Kassem GJ, Grivaux M. Debieuvre D, et al. Among authors: goarant e. Bull Cancer. 2017 Oct;104(10):840-849. doi: 10.1016/j.bulcan.2017.07.008. Epub 2017 Sep 29. Bull Cancer. 2017. PMID: 28965729
Five-year survival for lung cancer patients managed in general hospitals.
Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM, Prudhomme A, Carbonnelle M, Goarant E, Maury B, Bedossa A, Blanchon F. Grivaux M, et al. Among authors: goarant e. Rev Mal Respir. 2011 Sep;28(7):e31-8. doi: 10.1016/j.rmr.2008.07.001. Epub 2011 Aug 2. Rev Mal Respir. 2011. PMID: 21943545
[Invasion of the pulmonary artery by an undifferentiated carcinoma].
Millet A, Morel H, Sanchez O, Meyer G, Le Roy Ladurie F, Dartevelle P, Dulmet E, Goarant E, Curran Y. Millet A, et al. Among authors: goarant e. Rev Mal Respir. 2008 Jan;25(1):63-7. doi: 10.1016/s0761-8425(08)70468-6. Rev Mal Respir. 2008. PMID: 18288053 French.
[Five year survival for lung cancer patients managed in general hospitals].
Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM, Prud'homme A, Carbonnelle M, Goarant E, Maury B, Bedossa A, Blanchon F. Grivaux M, et al. Among authors: goarant e. Rev Mal Respir. 2009 Jan;26(1):37-44. doi: 10.1016/s0761-8425(09)70132-9. Rev Mal Respir. 2009. PMID: 19212288 French.